Paediatric The recommended oral dose in paediatrics is based on a population pharmacokinetic analysis of data obtained from 47 immunocompromised paediatric patients aged 2 to < 12 years old who were evaluated in a pharmacokinetic study examining multiple oral suspension doses of 4 and 6 mg/ kg twice daily.
Mainitud uuring hõlmas suukaudse suspensiooni korduvat manustamist annuses 4 mg/ kg ja 6 mg/ kg kaks korda ööpäevas.